Common use of Defined Term Section Clause in Contracts

Defined Term Section. Delaware Act 1.1 Dissenting Shares 1.7(a) Effective Time 1.1 Employee Benefit Plan 2.17(a)(i) Environmental Law 2.18(a) ERISA 2.17(a)(ii) ERISA Affiliate 2.17(a)(iii) Exchange Act 3.7(g) Exchange Agent 1.6(b) FDA 2.26 FINRA 3.4 GAAP 2.7 General Release Agreement Recitals Governmental Entity 2.4 Health Care Laws 2.26 Indemnified Executives 4.9(b) Intellectual Property 2.23 Laws 2.4 Letter of Transmittal 1.6(c) Lock-Up and No Shorting Agreements 5.1(i) Material Contract(s) 2.12(b) Merger Recitals Merger Shares 1.5(b) Minimum Amount Recitals Ordinary Course of Business 2.5(b) OTC Markets 3.2 Parent Introduction Parent Auditor 3.27 Parent Certificate 5.3(j) Parent Common Stock Recitals Parent Confidential Information 4.7(b) Parent Disclosure Schedule Article III Parent Equity Plan 4.14 Parent Financial Statements 3.8 Parent Material Adverse Effect 3.1 Parent Reports 3.6 Parent Subsidiary 2.5(a) Party Introduction Permits 2.24 Person 1.6(d) Placement Agent 2.21 Private Placement Offering Recitals Purchase Price Recitals Reasonable Best Efforts 4.1 Requisite Stockholder Approval 5.1(a) Restated Term Loan Recitals SEC 1.15 Securities Act 1.15 Security Interest 2.5(b) Series AA Preferred Stock 1.5(c) Series AB Preferred Stock 1.5(b)

Defined Term Section. Delaware Act 1.1 Dissenting Shares 1.7(aHoldings Preferred Stock 3.02(a) Effective Time 1.1 Employee Benefit Plan 2.17(a)(iHoldings Series A Preferred Stock 3.02(a) Environmental Law 2.18(aHoldings Series B Preferred Stock 3.02(a) ERISA 2.17(a)(iiHoldings Stockholder Approval 3.22(a) ERISA Affiliate 2.17(a)(iiiIndebtedness 8.11 Indemnified Parties 5.08(b) Exchange Act 3.7(gIndemnified Party 5.08(b) Exchange Agent 1.6(b) FDA 2.26 FINRA 3.4 GAAP 2.7 General Release Agreement Recitals Governmental Entity 2.4 Health Care Laws 2.26 Indemnified Executives 4.9(bInitial Alpha Director Designees 1.04(a) Intellectual Property 2.23 Laws 2.4 Letter of Transmittal 1.6(cRights 3.15(a) Lock-Up and No Shorting Agreements 5.1(iJoint Proxy Statement 3.07(ii) Material Contract(sKESP 5.09(c) 2.12(bknowledge 8.11 Law 3.04(a)(ii) Lien 8.11 Materially Burdensome Conditions 5.07(a) Merger Recitals Merger Shares 1.5(bConsideration 1.05(b)(iii) Minimum Amount Recitals Ordinary Course MergerSub 1 Preamble MergerSub 2 Preamble New Option 2.03 NYSE 8.11 Outside Date 8.11 Permit 8.11 Permitted Liens 8.11 Person 8.11 Proceeding 3.10(a) Release 3.14(i)(v) Representatives 8.11 Required Nomination Period 1.04(b) Reverse Termination Fee 7.03(g) SEC 3.04(b)(ii) Second Effective Time 1.02(b) Secretary of Business 2.5(bState 1.02(b) OTC Markets 3.2 Parent Introduction Parent Auditor 3.27 Parent Certificate 5.3(j) Parent Common Stock Recitals Parent Confidential Information 4.7(b) Parent Disclosure Schedule Article III Parent Equity Plan 4.14 Parent Financial Statements 3.8 Parent Material Adverse Effect 3.1 Parent Reports 3.6 Parent Subsidiary 2.5(a) Party Introduction Permits 2.24 Person 1.6(d) Placement Agent 2.21 Private Placement Offering Recitals Purchase Price Recitals Reasonable Best Efforts 4.1 Requisite Stockholder Approval 5.1(a) Restated Term Loan Recitals SEC 1.15 Section 262 1.07 Securities Act 1.15 Security Interest 2.5(b3.07(i) Series AA Preferred Stock 1.5(cSubsidiary 8.11 Surety Bonds 3.13(d) Series AB Preferred Stock 1.5(bSurviving Corporations 1.01 Takeover Laws 3.23 Tax 3.11(l) Tax Certificate 5.17(d)(vi) Taxing Authority 3.11(l) Tax Return 3.11(l) Termination Fee 7.03(d) Treasury Regulations 8.11 WARN 3.09(d) AGREEMENT AND PLAN OF MERGER (this “Agreement”), dated as of April 29, 2018, by and between ANR, Inc., a Delaware corporation (“ANR”), Alpha Natural Resources Holdings, Inc., a Delaware corporation (“Holdings”, and together with ANR, the “Alpha Parties”), Contura Energy, Inc., a Delaware corporation (“Contura”), Prime Acquisition I, Inc., a Delaware corporation and wholly owned Subsidiary of Contura (“MergerSub 1”), and Prime Acquisition II, Inc., a Delaware corporation and wholly owned Subsidiary of MergerSub 1 (“MergerSub 2”).

Defined Term Section. Delaware Act 1.1 Recitals Dissenting Shares 1.5(a) Dissenting Stockholder 1.5(d) Distributable Reserve Amount 1.9(c) Earnout Consideration 1.7(a) Earnout Determination Date 1.7(a)(ii) Effective Time 1.1 Employee Benefit Plan 2.17(a)(i1.2(a) Environmental Law 2.18(aElecting Accredited Company Stockholder 1.3(a) ERISA 2.17(a)(iiEmployment Offer Letters Recitals Estimated Closing Cash 1.8(a) ERISA Affiliate 2.17(a)(iiiEstimated Closing Indebtedness 1.8(a) Exchange Act 3.7(gEstimated Closing Working Capital 1.8(a) Exchange Agent 1.6(bEstimated Company Transaction Expenses 1.8(a) FDA 2.26 FINRA 3.4 GAAP 2.7 General Release Agreement Excess Dissenting Share Payments 1.5(c) Final Closing Cash 1.8(b) Final Closing Indebtedness 1.8(b) Final Closing Working Capital 1.8(b) Final Company Transaction Expenses 1.8(b) First Earnout Determination Date 1.7(a)(i) Fundamental Representation Payment Amount 7.2(g)(ii) Inbound Licenses 3.19(d) Indemnified Amounts 7.3 Information Security Program 3.19(i) Initial Consenting Stockholders Recitals Governmental Entity 2.4 Health Care Laws 2.26 Indemnified Executives 4.9(bInterim Period 5.8 IP Licenses 3.19(d) IPO 5.12 Key Employees Recitals L▇▇▇▇▇▇▇ Side Letter 2.2(d) Maximum Earnout Consideration 1.7(a) Merger Preamble Merger Sub Preamble Merger Recitals New Arrangements 5.3(b) Notice of Disagreement 1.8(d) Outbound Licenses 3.19(d) Outside Date 8.1(c) Parent Preamble Parent Indemnitees 7.2(a) Parent Indemnity Threshold Basket 7.2(g) Parent Intellectual Property 2.23 Laws 2.4 Letter of Transmittal 1.6(c4.10(a) Lock-Up and No Shorting Agreements 5.1(i) Material Contract(s) 2.12(b) Merger Recitals Merger Shares 1.5(b) Minimum Amount Recitals Ordinary Course of Business 2.5(b) OTC Markets 3.2 Parent Introduction Parent Auditor 3.27 Parent Certificate 5.3(j) Parent Common Stock Recitals Parent Confidential Information 4.7(b) Parent Disclosure Schedule Article III Parent Equity Plan 4.14 Parent Financial Statements 3.8 4.9(a) Parent Material Adverse Effect 3.1 Option 1.4(a) Parent Reports 3.6 Permits 4.15 Parent Subsidiary 2.5(aPlans 4.7(c) Party Introduction Permits 2.24 Person 1.6(d) Placement Parent Software 4.10 Paying Agent 2.21 Private Placement Offering Recitals Purchase Price Recitals Reasonable Best Efforts 4.1 Requisite Stockholder Approval 5.1(a) Restated Term Loan Recitals SEC 1.15 Securities Act 1.15 Security Interest 2.5(b) Series AA Preferred Stock 1.5(c) Series AB Preferred Stock 1.5(b1.6(b)(i)

Defined Term Section. Delaware Act 1.1 Dissenting Shares 1.7(a) Effective Time 1.1 Employee Benefit Plan 2.17(a)(i1.01(b) Environmental Law 2.18(aEnd Date 9.01(c) ERISA 2.17(a)(iiExisting D&O Policy 7.09(b) ERISA Affiliate 2.17(a)(iiiForm A Per Unit Consideration 2.02(b)(x) Exchange Act 3.7(gForm A Unit 2.02(a)(i) Exchange Agent 1.6(bForm B Per Unit Consideration 2.02(b)(v) FDA 2.26 FINRA 3.4 GAAP 2.7 General Release Agreement Recitals Governmental Entity 2.4 Health Care Laws 2.26 Form B Unit 2.02(a)(ii) GrafTech Preamble GrafTech Contracts 5.13(b) GrafTech Disclosure Schedule Article V Guaranteed Obligations 7.19(a) Guarantor 7.19(a) Indemnified Executives 4.9(bLoss 10.04(b) Intellectual Property 2.23 Laws 2.4 Indemnitee 10.04(a) Indemnitor 10.04(a) Key Member Fundamental Representations 8.02(a) Letter of Transmittal 1.6(c) Lock-Up and No Shorting Agreements 5.1(i2.06(c) Material Contract(sContracts 3.11(a) 2.12(bMaximum Premium 7.09(b) Merger Recitals 1.01(a) Merger Shares 1.5(bConsideration 2.02(b) Minimum Amount Recitals Ordinary Course Merger Consideration Fund 2.06(a) Merger Sub Preamble Monthly Financial Statements 2.07(a) Notice of Business 2.5(bClaim 10.04(a) OTC Markets 3.2 Objection Notice 2.07(e) Old C/G Members 7.22 Parent Introduction Preamble Parent Auditor 3.27 Parent Certificate 5.3(jCertificates 2.06(a) Parent Common Shares Consideration 2.02(b)(iii) Paying Agent 2.06(a) Permitted Tax Distributions 3.08 Pre-Closing Periods 7.11(b) Prior Tax Matters Partner 7.11(b) Promissory Note 2.02(b)(iv) Promissory Note Per Form B Unit Consideration 2.02(b)(viii) Registration Rights and Stockholders’ Agreement 7.14 Regulation D 2.09 Requisite Regulatory Approvals 8.01(a)(i) Restricted Period 7.18(a) Restricted Persons 7.18(a) Second Request 7.03(d) Securities 4.02(f)(i) Site 7.22 Software License 3.10(a) Stated C/G Amount 2.02(b)(i) Stock Recitals Parent Confidential Information 4.7(bPer Form B Unit Consideration 2.02(b)(vii) Parent Disclosure Schedule Article III Parent Equity Plan 4.14 Parent Financial Statements 3.8 Parent Material Adverse Effect 3.1 Parent Reports 3.6 Parent Subsidiary 2.5(aSurviving Entity 1.01(a) Party Introduction Permits 2.24 Person 1.6(dTotal Cash Amount 2.02(b)(xii) Placement Agent 2.21 Private Placement Offering Recitals Purchase Price Recitals Reasonable Best Efforts 4.1 Requisite Stockholder Approval 5.1(aTotal Cash to Form A Amount 2.02(b)(ix) Restated Term Loan Recitals SEC 1.15 Securities Total Note Amount 2.02(b)(iv) Total Share Amount 2.02(b)(ii) Total Units 2.02(b)(xi) USRPIs 3.12 WARN Act 1.15 Security Interest 2.5(b) Series AA Preferred Stock 1.5(c) Series AB Preferred Stock 1.5(b3.15(c)

Defined Term Section. Delaware Act 1.1 Dissenting Shares 1.7(aGrafTech Surviving Entity 1.01(a) GSHC Units 2.02(b)(i) Guaranteed Obligations 7.19(a) Guarantor 7.19(a) Indemnified Loss 10.04(b) Indemnitee 10.04(a) Indemnitor 10.04(a) Initial Effective Time 1.1 Employee Benefit Plan 2.17(a)(i1.01(b) Environmental Law 2.18(aKey Partner Fundamental Representations 8.02(a)(iii) ERISA 2.17(a)(ii) ERISA Affiliate 2.17(a)(iii) Exchange Act 3.7(g) Exchange Agent 1.6(b) FDA 2.26 FINRA 3.4 GAAP 2.7 General Release Agreement Recitals Governmental Entity 2.4 Health Care Laws 2.26 Indemnified Executives 4.9(b) Intellectual Property 2.23 Laws 2.4 Letter of Transmittal 1.6(c) Lock-Up and No Shorting Agreements 5.1(i2.06(c) Material Contract(sContracts 3.11(a) 2.12(bMaximum Premium 7.09(b) Merger Recitals Consideration Fund 2.06(a) Merger Shares 1.5(bFilings 1.02(b) Minimum Amount Recitals Ordinary Course Merger Subs Preamble Mergers 1.02(a) Monthly Financial Statements 2.07(a) Notice of Business 2.5(bClaim 10.04(a) OTC Markets 3.2 Parent Introduction Parent Auditor 3.27 Parent Certificate 5.3(jObjection Notice 2.07(e) Parent Common Stock Recitals Preamble Parent Confidential Information 4.7(bCertificates 2.06(a) Parent Shares Consideration 2.02(b)(iv) Partnership Preamble Partnership Certificate of Merger 1.02(b) Partnership Disclosure Schedule Article III Parent Equity Plan 4.14 Parent Partnership Indemnified Persons 7.09(a)(i) Partnership Merger 1.02(a) Partnership Merger Consideration 2.02(b) Partnership Permits 3.19 Paying Agent 2.06(a) Permitted Tax Distributions 3.08 Pre-Closing Periods 7.11(b) Promissory Note 2.02(b)(iv) Promissory Note Per Form B Unit Consideration 2.02(b)(ix) Registration Rights and Stockholders’ Agreement 7.14 Registration Statement 7.08 Regulation D 2.09 Requisite Regulatory Approvals 8.01(a)(i) Restricted Period 7.18(a) Restricted Persons 7.18(a) Seadrift Annual Financial Statements 3.8 Parent Material Adverse Effect 3.1 Parent Reports 3.6 Parent Subsidiary 2.5(a3.06(a) Party Introduction Permits 2.24 Person 1.6(dSeadrift Interim Financial Statements 3.06(b) Placement Agent 2.21 Private Placement Offering Recitals Purchase Price Recitals Reasonable Best Efforts 4.1 Requisite Stockholder Approval 5.1(aSeadrift Surviving Entity 1.02(a) Restated Term Loan Recitals SEC 1.15 Second Request 7.03(d) Securities Software License 4.02(f)(i) 3.10(a) Stated Seadrift Amount 2.02(b)(ii) Stock Per Form B Unit Consideration 2.02(b)(viii) Surviving Entities 1.02(a) Total Cash Amount 2.02(b)(xiii) Total Cash to Form A Amount 2.02(b)(x) Total Note Amount 2.02(b)(v) Total Share Amount 2.02(b)(iii) Total Units 2.02(b)(xii) USRPIs 3.12 WARN Act 1.15 Security Interest 2.5(b) Series AA Preferred Stock 1.5(c) Series AB Preferred Stock 1.5(b3.15(c)

Defined Term Section. Delaware Act 1.1 Dissenting Shares 1.7(aNew Plans 6.06(c) Effective Time 1.1 Employee Benefit Plan 2.17(a)(i) Environmental Law 2.18(a) ERISA 2.17(a)(ii) ERISA Affiliate 2.17(a)(iii) Exchange Act 3.7(g) Exchange Agent 1.6(b) FDA 2.26 FINRA 3.4 GAAP 2.7 General Release Agreement Recitals Governmental Entity 2.4 Health Care Laws 2.26 Indemnified Executives 4.9(b) Intellectual Property 2.23 Laws 2.4 Letter of Transmittal 1.6(c) Lock-Up and No Shorting Agreements 5.1(i) Material Contract(s) 2.12(b) Merger Recitals Merger Shares 1.5(b) Minimum Amount Recitals Ordinary Course of Business 2.5(b) OTC Markets 3.2 Parent Introduction Parent Auditor 3.27 Parent Certificate 5.3(jNew Term Loan Facility 9.03 NYSE 2.02(i) Parent Common Stock Preamble Parent ADSs Recitals Parent Confidential Information 4.7(bAdverse Recommendation Change 5.03(a) Parent Alternative Proposal 5.03(e) Parent Alternative Transaction 5.03(e) Parent Articles 4.03(a) Parent Board Recitals Parent Circular 4.05(b) Parent Disclosure Schedule Letter Article III IV Parent Equity Plan 4.14 Parent Financial Statements 3.8 Entities Preamble Parent Material Adverse Effect 3.1 9.03 Parent Notice 5.03(b) Parent Ordinary Shares Recitals Parent Prospectus 4.05(b) Parent Public Reports 3.6 4.06(a) Parent Recommendation 4.04(b) Parent Registered Intellectual Property 4.12(a) Parent Share Awards 9.03 Parent Share Plans 4.03(a) Parent Shareholder Approval 4.04(d) Parent Shareholders Meeting 4.05(b) Parent Subsidiary 2.5(a4.01(b) Party Introduction Parent Termination Fee 6.08(c) Parent Voting Debt 4.03(a) PBGC 6.06(e) Per Share Cash Consideration 2.01(c)(ii) Per Share Stock Consideration 2.01(c)(i) Permits 2.24 Person 1.6(d3.01 person 9.03 Plan of Merger Recitals Prospectus Rules 9.03 Proxy Statement 3.05(b) Placement Agent 2.21 Private Placement Offering Recitals Purchase Price Recitals Reasonable Best Efforts 4.1 Requisite Stockholder Approval 5.1(aRegulatory Requirement 6.03(c) Restated Term Loan Recitals Representatives 5.02(a) Required Company Shareholder Approvals 3.04(c) Restraints 7.01(f) Required Payments 4.14(a) Rollover RSU 9.03 RSU Exchange Ratio 9.03 ▇▇▇▇▇▇▇▇-▇▇▇▇▇ Act 3.06(b) Schedule 13E-3 3.05(b) SEC 1.15 3.05(b) Securities Act 1.15 Security Interest 2.5(b3.06(b) Series AA A Preferred Stock 1.5(c) Series AB Preferred Stock 1.5(b3.03(a)